Gdynia, Poland

Krzysztof Kazimierz Lemke

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Krzysztof Kazimierz Lemke: Innovator in Anticancer Fusion Proteins

Introduction

Krzysztof Kazimierz Lemke is a notable inventor based in Gdynia, Poland. He has made significant contributions to the field of biotechnology, particularly in the development of anticancer fusion proteins. With a total of two patents to his name, Lemke's work focuses on innovative solutions for cancer treatment.

Latest Patents

Lemke's latest patents include an anticancer fusion protein comprising TRAIL and interferon. This fusion protein features domain (a), which is a functional fragment of the hTRAIL protein sequence, beginning with an amino acid at a position not lower than hTRAIL95. Additionally, it includes domain (b), which is a sequence of an immunostimulating effector peptide. This fusion protein is designed for the treatment of cancer diseases. Another significant patent is an anticancer fusion protein comprising TRAIL. This recombinant fusion protein also includes domain (a), a functional fragment of soluble hTRAIL protein sequence, and domain (b), a sequence of pro-apoptotic effector peptide. This fusion protein demonstrates anticancer activity and includes the nucleotide sequence coding the fusion protein, expression vector, and host cell for its preparation.

Career Highlights

Throughout his career, Lemke has worked with prominent companies in the biotechnology sector, including Adamed Sp. z o.o. and Adamed Pharma S.A. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Lemke has collaborated with notable colleagues such as Jerzy Szczepan Pieczykolan and Sebastian Dominik Pawlak. These collaborations have likely enhanced his research and development efforts in the field of anticancer therapies.

Conclusion

Krzysztof Kazimierz Lemke is a distinguished inventor whose work in anticancer fusion proteins has the potential to significantly impact cancer treatment. His innovative patents and collaborations reflect his commitment to advancing biotechnology for therapeutic purposes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…